openPR Logo
Press release

Obesity Therapeutic and Disease Pipeline Review H2

11-27-2017 10:56 AM CET | Health & Medicine

Press release from: WISE GUY RESEARCH CONSULTANTS PVT LTD

Summary
Obesity is defined as having an excessive amount of body fat. Obesity increases risk of diseases and health problems such as heart disease, diabetes and high blood pressure. The predisposing factors include age, family history, quitting smoking, lack of sleep and certain medications. Treatment includes healthy lifestyle, medications and surgery.

Report Highlights
Pharmaceutical and Healthcare latest pipeline guide Obesity - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Obesity (Metabolic Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2530975-obesity-pipeline-review-h2-2017

The Obesity (Metabolic Disorders) pipeline guide also reviews of key players involved in therapeutic development for Obesity and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 1, 4, 16, 28, 125 and 27 respectively. Similarly, the Universities portfolio in Phase I, Preclinical and Discovery stages comprises 1, 57 and 13 molecules, respectively.

Obesity (Metabolic Disorders) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Obesity (Metabolic Disorders).
- The pipeline guide reviews pipeline therapeutics for Obesity (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Obesity (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Obesity (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews latest news related to pipeline therapeutics for Obesity (Metabolic Disorders)

Reasons to buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Obesity (Metabolic Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Obesity (Metabolic Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Table of Content: Key Points
Table of Contents 2
Introduction 6
Obesity - Overview 7
Obesity - Therapeutics Development 8
Obesity - Therapeutics Assessment 36
Obesity - Companies Involved in Therapeutics Development 56
Obesity - Drug Profiles 98
Obesity - Dormant Projects 461
Obesity - Discontinued Products 476
Obesity - Product Development Milestones 480
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2530975-obesity-pipeline-review-h2-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

WISE GUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Obesity Therapeutic and Disease Pipeline Review H2 here

News-ID: 833345 • Views: 194

More Releases from WISE GUY RESEARCH CONSULTANTS PVT LTD

Dry Shampoo Market 2020: Key Players – Church & Dwight, P&G, Unilever, L'Oreal …
Dry Shampoo Industry Description This report studies the Dry Shampoo market, From reviving limp hair and banishing greasy scalps to boosting voluminous roots, dry shampoo offers a magical promise to users: fresher hair, no soap and water required. Dry Shampoo is more convenient. The manufacturers and consumers are concentrated in Europe, USA, China, and Japan. North America is the largest consumption regions; Europe is following with share about 38.8%. The revenue share of
Automotive Financing Market 2020: Key Players – Bank of America, Ally Financia …
Automotive Financing Industry Description Wiseguyreports.Com Adds “Automotive Financing -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database Automotive Financing market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Automotive Financing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type
Softlines Testing, Inspection, and Certification Market 2020: Key Players – In …
Softlines Testing, Inspection, and Certification Industry Description Wiseguyreports.Com Adds “Softlines Testing, Inspection, and Certification -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database Softlines Testing, Inspection, and Certification market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Softlines Testing, Inspection, and Certification market will be able to gain the upper hand as they use the report as a
Wi-Fi Wireless Antenna Market 2020: Key Players – Harada, Amphenol, Sunway, Mo …
Wi-Fi Wireless Antenna Industry Description Wiseguyreports.Com Adds “Wi-Fi Wireless Antenna -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2025” To Its Research Database Wi-Fi Wireless Antenna market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Wi-Fi Wireless Antenna market will be able to gain the upper hand as they use the report as a powerful resource. The segmental

All 5 Releases


More Releases for Obesity

Fast Food and Obesity
Most of the fast food in the market contains a large quantity of sugar, #carbs and fats with a lesser quantity of vitamins and minerals. The unhealthy food ingredients in the fast food are further increased with increased portion size. The person will still consume the whole meal regardless of being completely full. People cannot stop ravishing on fast food because it is available for low cost and in close
Obesity Management Congress 2018
Obesity can be managed by combination of lifestyle change, exercise and healthy diet plans. In case of severe Obesity bariatric surgery and medications will be employed. People who have gone through bariatric surgery which have suppressed hunger and the mechanism for which causes obesity based type 2 diabetes is reversed and it also causes sixty to eighty percent weight loss for a long term. But it has it cons
Obesity Management Market | Global Industry Analysis 2027
High costs involved in the research & development (R&D) of obesity drugs, coupled with limited financial support, are collectively a great challenge for adoption of obesity management solutions. Additionally, long gestation time needed for R&D activities, and the inclusion of clinical trials required to test these drugs hikes the expenditure significantly. Considering this scenario, manufacturers are being cautious while seeking better return on investments. In the long run, risks and
Obesity Treatment Market driven by rise in childhood obesity rates
Obesity is a disorder in which excess body fat gets accumulated to such extent that it may have negative effects on health. It occurs over time when people eat more calories than they utilize. The reasons for obesity can be medical problems, inactivity, genetics, family lifestyle, unhealthy diet, medications, age, and pregnancy. Being obese increases the risk of diabetes, heart disease, stroke, arthritis, and some type of cancers. Obesity treatment
Diabetes & Obesity Drug Development Pipeline Review, 2016
ReportsWorldwide has announced the addition of a new report title Diabetes & Obesity Drug Development Pipeline Review, 2016 to its growing collection of premium market research reports. The diabetes and obesity disease cluster is currently dominated by therapeutics indicated for type 1 diabetes mellitus (T1DM) and type 2 diabetes mellitus (T2DM), and the majority of the pipeline, in terms of both quantity and quality of products, is attributable to these indications.
Obesity Epidemic Among Children Triggering Numerous Ailments
I-Newswire (February 22, 2012) Former U.S. Surgeon General Richard Carmona recently stated, “Because of the increasing rates of obesity, unhealthy eating habits and physical inactivity, we may see the first generation that will be less healthy and have a shorter life expectancy than their parents.” Carmona’s statement reflects findings that nearly one in three children is overweight or obese. Children are developing obesity-related diseases, previously considered primarily adult